A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage

Dabigatran: Is There a Role for Coagulation Assays in Guiding Therapy?

(2013) Luigi Brunetti et al.   ANNALS OF PHARMACOTHERAPY

Extracorporeal Therapy for Dabigatran Removal in the Treatment of Acute Bleeding: A Single Center Experience

(2013) T. Singh et al.   Clinical Journal of the American Society of Nephrology

Reversing Dabigatran in Life-Threatening Bleeding Occurring During Cardiac Ablation With Factor Eight Inhibitor Bypassing Activity

(2013) William E. Dager et al.   CRITICAL CARE MEDICINE

Evaluation of coagulation assays versus LC-MS/MS for determinations of dabigatran concentrations in plasma

(2013) Jovan P. Antovic et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Measuring the anticoagulant effects of target specific oral anticoagulants—reasons, methods and current limitations

(2013) Helen Mani et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Effective elimination of dabigatran by haemodialysis

(2013) Stephan Formella et al.   THROMBOSIS AND HAEMOSTASIS

The Effect of Dabigatran on Select Specialty Coagulation Assays

(2012) Dorothy M. Adcock et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors

(2012) Scott Kaatz et al.   AMERICAN JOURNAL OF HEMATOLOGY

Removal of Dabigatran by Hemodialysis

(2012) Don N. Chang et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Interpretation of Point-of-care INR Results in Patients Treated with Dabigatran

(2012) Joanne van Ryn et al.   AMERICAN JOURNAL OF MEDICINE

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding

(2012) T. E. Warkentin et al.   BLOOD

Oral Anticoagulant Therapy

(2012) Walter Ageno et al.   CHEST

Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran

(2012) Jeffrey I. Weitz et al.   CIRCULATION

Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial

(2012) Antonio L. Dans et al.   CIRCULATION

Emergency Management of Bleeding Associated With Old and New Oral Anticoagulants

(2012) W. Frank Peacock et al.   CLINICAL CARDIOLOGY

Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban

(2012) Raphael Marlu et al.   THROMBOSIS AND HAEMOSTASIS

Impact of dabigatran on a large panel of routine or specific coagulation assays

(2012) Séverine Robert et al.   THROMBOSIS AND HAEMOSTASIS

Dabigatran Etexilate

(2011) Graeme J. Hankey et al.   CIRCULATION

Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate

(2011) Elise S. Eerenberg et al.   CIRCULATION

Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial

(2011) J. Oldgren et al.   EUROPEAN HEART JOURNAL

Hemostatic Therapy in Experimental Intracerebral Hemorrhage Associated With the Direct Thrombin Inhibitor Dabigatran

(2011) Wei Zhou et al.   STROKE

Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists

(2011) Chiara Marchesi et al.   THROMBOSIS AND HAEMOSTASIS

Influence of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Oral Dabigatran Etexilate

(2010) Joachim Stangier et al.   CLINICAL PHARMACOKINETICS

Safety of Recombinant Activated Factor VII in Randomized Clinical Trials

(2010) Marcel Levi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overview of Platelet Transfusion

(2010) Jeffrey McCullough   SEMINARS IN HEMATOLOGY

Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity

(2010) Joachim Stangier et al.   THROMBOSIS AND HAEMOSTASIS

Pharmacology, Pharmacokinetics, and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor

(2009) Joachim Stangier et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Pharmacokinetics and Pharmacodynamics of the Direct Oral Thrombin Inhibitor Dabigatran in Healthy Elderly Subjects

(2009) Joachim Stangier et al.   CLINICAL PHARMACOKINETICS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Recombinant factor VIIa for warfarin-associated intracranial bleeding

(2008) Can Ilyas et al.   JOURNAL OF CLINICAL ANESTHESIA